Exclusive: Pharma Trade Groups Team Up In China To Improve Compliance
This article was originally published in PharmAsia News
Nine pharmaceutical industry associations in China have come together to request that member companies ensure strict compliance with business ethics. In a meeting set for Oct. 29, the trade groups will endorse the Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector.
You may also be interested in...
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.